References
Chambon P . A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940–954.
Marinelli A, Bossi D, Pelicci PG, Minucci S . A redundant oncogenic potential of the retinoic receptor (RAR) alpha, beta and gamma isoforms in acute promyelocytic leukemia. Leukemia 2007; 21: 647–650.
Marinelli A, Bossi D, Pelicci PG, Minucci S . Redundant function of retinoic acid receptor isoforms in leukemogenesis unravels a prominent function of genome topology and architecture in the selection of mutagenic events in cancer. Leukemia 2009; 23: 417–419.
Chen K, Wallis JW, McLellan MD, Larson DE, Kalicki JM, Pohl CS et al. BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods 2009; 6: 677–681.
Chen X, Schulz-Trieglaff O, Shaw R, Barnes B, Schlesinger F, Källberg M et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 2016; 32: 1220–1222.
Such E, Cervera J, Valencia A, Barragán E, Ibañez M, Luna I et al. A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia. Blood 2011; 117: 242–245.
Such E, Cordon L, Sempere A, Villamón E, Ibañez M, Luna I et al. In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene. Ann Hematol 2014; 93: 1931–1933.
Qiu JJ, Zeisig BB, Li S, Liu W, Chu H, Song Y et al. Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia. Leukemia 2015; 29: 1153–1162.
Acknowledgements
We thank K-S Park, K-S Lee and T-Y Park for good practice performing molecular studies including sequencing and PCR experiments.
Author contributions
J-SH and C-SK designed the molecular studies and wrote the paper; YRD was involved in the management of the patient and providing clinical data; CL analyzed the next-generation sequencing data; D-HK performed cytogenetic analyses and FISH experiments; and D-SJ, N-HR and WL performed morphologic analyses and supervised the molecular studies. All authors read and approved the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ha, JS., Do, Y., Ki, CS. et al. Identification of a novel PML-RARG fusion in acute promyelocytic leukemia. Leukemia 31, 1992–1995 (2017). https://doi.org/10.1038/leu.2017.167
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.167
- Springer Nature Limited
This article is cited by
-
Current views on the genetic landscape and management of variant acute promyelocytic leukemia
Biomarker Research (2021)
-
A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide
British Journal of Cancer (2019)
-
Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia
Leukemia (2018)